Reuters (4/12) reports, “The U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration have jointly issued warning letters to two websites for illegally selling Adderall, a treatment for attention deficit hyperactivity disorder [AD/HD].” These “warning letters were issued on March 30,” and now the two companies “have 15 business days to respond to the agencies and inform them of the steps being taken to address any violations and prevent their recurrence”.
Related Links:
— “FDA warns websites illegally selling ADHD drug Adderall, Reuters, April 12, 2022